(RTTNews) - LeMaitre Vascular, Inc. (LMAT), a medical device company, said on Monday that it intends to offer $150 million of convertible senior notes due 2030 in a private offering.
The company plans to use the net proceeds from this offering for working capital and other general purposes.
LeMaitre Vascular also expects to grant the initial purchasers of the notes an option to purchase up to an additional $22.500 million of notes.
LMAT was down by 4.16 percent at $96.50 in the pre-market trade on the Nasdaq.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
